Microvascular disease and risk of cardiovascular events among individuals with type 2 diabetes: a population-level cohort study-Reference-Cited by-同舟云学术

Microvascular disease and risk of cardiovascular events among individuals with type 2 diabetes: a population-level cohort study

Published:2016-07 Issue:7 Volume:4 Page:588-597
ISSN:2213-8587
Container-title:The Lancet Diabetes & Endocrinology
language:en
Short-container-title:The Lancet Diabetes & Endocrinology

Author:

Brownrigg Jack R W,Hughes Cian O,Burleigh David,Karthikesalingam Alan,Patterson Benjamin O,Holt Peter J,Thompson Matthew M,de Lusignan Simon,Ray Kausik K,Hinchliffe Robert J

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference39 articles.

1. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies;Lancet,2010

2. Diabetes mellitus, fasting glucose, and risk of cause-specific death;Seshasai;N Engl J Med,2011

3. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines;Stone;Circulation,2014

4. Prediction models for the risk of cardiovascular disease in patients with type 2 diabetes: a systematic review;van Dieren;Heart,2012

5. Predictive value of cardiac autonomic neuropathy in diabetic patients with or without silent myocardial ischemia;Valensi;Diabetes Care,2001

Cited by 196 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive Factors for Predicting the Complications of Diabetes Mellitus: A Systematic Review;Current Diabetes Reviews;2024-11

2. Modern Challenges in Type 2 Diabetes: Balancing New Medications with Multifactorial Care;Biomedicines;2024-09-07

3. Prevalence, impact and management of hypertension-mediated organ damage in type 2 diabetes patients;Medicina de Familia. SEMERGEN;2024-09

4. Triglyceride/High Density Lipoprotein Cholesterol Index and Future Cardiovascular Events in Diabetic Patients without Known Cardiovascular Disease;2024-09-01

5. Dapagliflozin in Heart Failure, Type 2 Diabetes, and Neuropathy;JACC: Heart Failure;2024-09